Spread of Mink SARS-CoV-2 Variants in Humans: A Model of Sarbecovirus Interspecies Evolution

Christian A Devaux1,2,3, Lucile Pinault1, Jérémy Delerce1

  • 1Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.

Insights

SARS-CoV-2 variants in minks show increased affinity for human ACE2, potentially impacting vaccine effectiveness. However, key antibody targets remain largely unaffected, suggesting continued vaccine utility.

Area of Science:

  • Virology
  • Molecular Biology
  • Evolutionary Biology

Background:

  • The emergence of SARS-CoV-2 variants raised concerns about vaccine escape.
  • Mink-associated variants were found in humans, prompting investigations into their evolutionary dynamics.

Purpose of the Study:

  • To investigate SARS-CoV-2 variant circulation in minks as a model for sarbecovirus interspecies evolution.
  • To compare human and mink receptor interactions and analyze mutation impacts on the spike protein.

Main Methods:

  • Comparative analysis of human and mink angiotensin I converting enzyme 2 (ACE2) and neuropilin 1 (NRP-1) receptors.
  • Sequence comparison of SARS-CoV-2 from human and mink hosts.
  • 3D structural analysis of spike protein mutations and prediction of linear epitopes.

Main Results:

  • Mink-selected variants (Y453F/D614G) exhibit enhanced affinity for human ACE2.
  • These variants show reduced susceptibility to neutralization by a specific monoclonal antibody.
  • Major predicted neutralizing antibody epitopes are unlikely to be lost due to these mutations.

Conclusions:

  • Mink-derived SARS-CoV-2 variants possess characteristics that could influence interspecies transmission and immune evasion.
  • The findings support the continued rational use of SARS-CoV-2 vaccines while highlighting the need for ongoing surveillance.

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.0K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
35.1K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Convergent Evolution01:54

Convergent Evolution

Evolution shapes the features of organisms over time, ensuring that they are suited for the environments in which they live. Sometimes, selection pressure leads to the rise of similar but unrelated adaptations in organisms with no recent common ancestors, a process known as convergent evolution.
29.7K